Unadjusted proportions and 95% CI for the use of lipid-lowering medication after diabetes diagnosis in two new diabetes cohorts by CHD status at the time of diabetes diagnosis
| Lipid-lowering medication | Diabetes-only | CHD before diabetes | Coincident CHD and diabetes | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| The cohort 2000 | The cohort 2006 | The cohort 2000 | The cohort 2006 | The cohort 2000 | The cohort 2006 | |||||||
| Per cent | 95% CI | Per cent | 95% CI | Per cent | 95% CI | Per cent | 95% CI | Per cent | 95% CI | Per cent | 95% CI | |
| Men | 18 | (17 to 19) | 38 | (37 to 39) | 52 | (49 to 55) | 79 | (77 to 81) | 59 | (55 to 63) | 80 | (77 to 84) |
| Women | 20 | (19 to 21) | 40 | (39 to 41) | 48 | (45 to 52) | 73 | (71 to 76) | 57 | (51 to 63) | 75 | (70 to 81) |
| Age groups | ||||||||||||
| 30–49 | 14 | (13 to 16) | 28 | (26 to 29) | 51 | (37 to 64) | 77 | (66 to 87) | 59 | (47 to 71) | 79 | (68 to 90) |
| 50–59 | 21 | (20 to 22) | 40 | (39 to 42) | 55 | (49 to 61) | 84 | (80 to 87) | 76 | (70 to 82) | 84 | (79 to 89) |
| 60–69 | 22 | (21 to 24) | 44 | (43 to 46) | 58 | (54 to 62) | 80 | (77 to 83) | 59 | (53 to 65) | 81 | (76 to 86) |
| 70–79 | 16 | (15 to 18) | 41 | (39 to 43) | 44 | (41 to 47) | 72 | (70 to 75) | 46 | (40 to 52) | 72 | (67 to 78) |
| Income quintile | ||||||||||||
| Lowest | 14 | (13 to 16) | 33 | (31 to 35) | 40 | (34 to 45) | 69 | (64 to 73) | 60 | (52 to 68) | 69 | (61 to 76) |
| 2nd | 19 | (17 to 20) | 39 | (37 to 41) | 46 | (42 to 50) | 75 | (72 to 78) | 51 | (45 to 57) | 79 | (73 to 85) |
| 3rd | 19 | (18 to 21) | 41 | (39 to 42) | 52 | (48 to 57) | 77 | (74 to 80) | 55 | (47 to 63) | 84 | (78 to 90) |
| 4th | 21 | (19 to 23) | 39 | (38 to 41) | 64 | (58 to 70) | 85 | (82 to 89) | 66 | (58 to 74) | 82 | (76 to 89) |
| Highest | 21 | (19 to 22) | 41 | (39 to 42) | 63 | (56 to 69) | 83 | (78 to 87) | 68 | (59 to 76) | 79 | (72 to 87) |
CHD, coronary heart disease.